+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brain Cancer Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035

  • PDF Icon

    Report

  • May 2025
  • Region: Global
  • BIS Research
  • ID: 6089554
10% Free customization
Description Jump to:
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Key factors driving this market include the increasing incidence of brain cancer, advancements in medical technology, and the growing focus on personalized medicine. Brain cancer, one of the most challenging types of cancer to treat, requires innovative solutions due to its complex nature.

Brain cancer involves abnormal cell growth in the brain that disrupts normal brain function. Treatments are becoming more sophisticated, targeting the tumour directly while preserving healthy brain tissue. Immunotherapies and personalized treatments tailored to the patient’s genetic makeup are gaining traction in this market.

Market Lifecycle Stage

The market for brain cancer treatments is transitioning from traditional methods (surgery, chemotherapy) to more targeted therapies and immunotherapy approaches. This shift is fuelled by the discovery of genetic markers and biomarkers associated with brain tumours, allowing for the development of precision medicine strategies. The approval of new biologics and immunotherapies represents a significant milestone in the treatment landscape for brain cancer.

North America holds a dominant position in the global brain cancer market, driven by its advanced healthcare infrastructure, high diagnosis rates, and strong presence of key pharmaceutical companies.

Demand - Drivers and Limitations

The global brain cancer market is driven by several key factors:

  • Increasing incidence of brain cancer
  • Advancements in medical technology
  • The increasing focus on precision medicine

Limitations:

  • High cost of therapies

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: This report provides valuable insights for pharmaceutical companies looking to innovate in brain cancer treatments, focusing on targeted therapies, immunotherapies, and precision medicine. It helps identify emerging trends in brain cancer treatment and potential gaps in the market.

Competitive Strategy: For pharmaceutical companies and healthcare providers, understanding current market dynamics, emerging trends, and key competitors is essential. This report equips stakeholders with the tools to assess market opportunities and stay competitive in the global brain cancer market.

Key Market Players and Competition Synopsis

The companies profiled in this report are selected based on expert insights, evaluating company coverage, product portfolio, and market penetration. Leading players in the global brain cancer market include pharmaceutical companies and service providers who hold substantial shares of the market.

Some of the prominent names established in this market are:

  • Merck & Co., Inc.
  • Novartis AG
  • Genentech
  • Orbus Therapeutics
  • VBL Therapeutics
  • DNAtrix

This product will be updated with the latest data at the time of order. Consequently, dispatch time for this product will be 7-10 business days.

Table of Contents

Executive SummaryMarket/Product DefinitionInclusion and Exclusion
1. Global Brain Cancer Market: Industry Outlook
1.1 Market Overview and Ecosystem
1.2 Epidemiological Analysis of Brain Cancer
1.2.1 By Region
1.3 Market Trends
1.4 Clinical Trials
1.4.1 By Phase
1.5 Regulatory Landscape Analysis
1.5.1 Legal Requirement and Framework in U.S.
1.5.2 Legal Requirement and Framework in E.U.
1.5.3 Legal Requirement and Framework in Asia-Pacific
1.5.4 Legal Requirement and Framework in Rest-of-the-World
1.6 Market Dynamics
1.6.1 Impact Analysis
1.6.2 Market Drivers
1.6.3 Market Restraints
1.6.4 Market Opportunities
2. Global Brain Cancer Market, by Region, $Million, 2023-2035
2.1 North America
2.1.1 Key Findings
2.1.2 Market Dynamics
2.1.3 Market Sizing and Forecast
2.1.3.1 North America Brain Cancer Market (by Country)
2.1.3.1.1 U.S.
2.1.3.1.2 Canada
2.2 Europe
2.2.1 Key Findings
2.2.2 Market Dynamics
2.2.3 Market Sizing and Forecast
2.2.3.1 Europe Brain Cancer Market (by Country)
2.2.3.1.1 Germany
2.2.3.1.2 France
2.2.3.1.3 Italy
2.2.3.1.4 U.K.
2.2.3.1.5 Rest-of-Europe
2.3 Asia-Pacific
2.3.1 Key Findings
2.3.2 Market Dynamics
2.3.3 Market Sizing and Forecast
2.3.3.1 Asia-Pacific Brain Cancer Market (by Country)
2.3.3.1.1 China
2.3.3.1.2 Japan
2.3.3.1.3 India
2.3.3.1.4 Rest-of-Asia-Pacific
2.4 Rest-of-the-World
2.4.1 Key Findings
2.4.2 Market Dynamics
2.4.3 Market Sizing and Forecast
3. Global Brain Cancer Market - Competitive Benchmarking and Company Profiles
3.1 Competitive Landscape
3.1.1 Key Strategies and Developments by Company
3.1.1.1 Funding Activities
3.1.1.2 Mergers and Acquisitions
3.1.1.3 Regulatory Approvals
3.1.1.4 Partnerships, Collaborations and Business Expansions
3.1.2 Key Developments Analysis
3.2 Company Profiles
3.2.1 Merck & Co., Inc.
3.2.1.1 Company Overview
3.2.1.2 Product Portfolio
3.2.1.3 Target Customers/End Users
3.2.1.4 Key Personnels
3.2.1.5 Analyst View
3.2.2 Novartis AG
3.2.2.1 Company Overview
3.2.2.2 Product Portfolio
3.2.2.3 Target Customers / End Users
3.2.2.4 Key Personnels
3.2.2.5 Analyst View
3.2.3 Genentech
3.2.3.1 Company Overview
3.2.3.2 Product Portfolio
3.2.3.3 Target Customers / End Users
3.2.3.4 Key Personnels
3.2.3.5 Analyst View
3.2.4 Orbus Therapeutics
3.2.4.1 Company Overview
3.2.4.2 Product Portfolio
3.2.4.3 Target Customers / End Users
3.2.4.4 Key Personnels
3.2.4.5 Analyst View
3.2.5 VBL Therapeutics
3.2.5.1 Company Overview
3.2.5.2 Product Portfolio
3.2.5.3 Target Customers / End Users
3.2.5.4 Key Personnels
3.2.5.5 Analyst View
3.2.6 DNAtrix
3.2.6.1 Company Overview
3.2.6.2 Product Portfolio
3.2.6.3 Target Customers / End Users
3.2.6.4 Key Personnels
3.2.6.5 Analyst View
4. Research Methodology
List of Figures
Figure: Global Brain Cancer Market, Dynamics Impact Analysis
Figure: Global Brain Cancer Market, Coverage
Figure: Global Brain Cancer Market, Key Trends, Impact Analysis
Figure: Global Brain Cancer Market, Competitive Landscape, January 2022- April 2025
List of Tables
Table: Global Brain Cancer Market, Dynamics and Impact Analysis
Table: Global Brain Cancer Market, Regulatory Landscape
Table: Global Brain Cancer Market, (by Region), $Million, 2023-2035

Companies Mentioned

  • Merck & Co., Inc.
  • Novartis AG
  • Genentech
  • Orbus Therapeutics
  • VBL Therapeutics
  • DNAtrix

Related Topics

Related Reports

Anaplastic Astrocytoma - Pipeline Insight, 2025 - Product Image

Anaplastic Astrocytoma - Pipeline Insight, 2025

  • Clinical Trials
  • 85 Pages
  • Global
From
Recurrent Anaplastic Astrocytomas - Pipeline Insight, 2025 - Product Image

Recurrent Anaplastic Astrocytomas - Pipeline Insight, 2025

  • Clinical Trials
  • 40 Pages
  • Global
From
Pontine Glioma Drugs Market Report 2025 - Product Image

Pontine Glioma Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Brain & Spinal Cord Cancer Market by Cancer Type, Treatment Type, Patient Age Group, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Brain & Spinal Cord Cancer Market by Cancer Type, Treatment Type, Patient Age Group, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 180 Pages
  • Global
From
Brain Cancer Drugs Market by Drug Class, Tumor Type, Route Of Administration, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Brain Cancer Drugs Market by Drug Class, Tumor Type, Route Of Administration, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.